.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Fish and Richardson
Citi
Covington
Queensland Health
Deloitte
Medtronic
Colorcon
Chinese Patent Office
Mallinckrodt

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017512

« Back to Dashboard

NDA 017512 describes DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in two NDAs. It is available from one supplier. Additional details are available on the DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER profile page.

The generic ingredient in DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER is calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate. There are two hundred and seventy drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate profile page.

Summary for 017512

Tradename:11
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 017512

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 017512 NDA Baxter Healthcare Corporation 0941-0409 0941-0409-05 3000 mL in 1 BAG (0941-0409-05)
DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 017512 NDA Baxter Healthcare Corporation 0941-0409 0941-0409-06 2000 mL in 1 BAG (0941-0409-06)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAPERITONEALStrength25.7MG/100ML;1.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100ML
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAPERITONEALStrength25.7MG/100ML;4.25GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100ML
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAPERITONEALStrength25.7MG/100ML;2.5GM/100ML;15.2MG/100ML;567MG/100ML;392MG/100ML
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Citi
Merck
Julphar
UBS
Fuji
US Army
Queensland Health
Argus Health
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot